Pulse Biosciences, Inc. (PLSE)
53.02
+0.34
(+0.65%)
USD |
NASDAQ |
Oct 23, 16:00
52.97
-0.05
(-0.09%)
After-Hours: 20:00
Pulse Biosciences Enterprise Value : 3.659B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.659B |
| October 22, 2026 | 3.635B |
| October 21, 2026 | 3.538B |
| October 20, 2026 | 3.505B |
| October 19, 2026 | 3.272B |
| October 16, 2026 | 3.051B |
| October 15, 2026 | 3.133B |
| October 14, 2026 | 3.185B |
| October 13, 2026 | 3.342B |
| October 12, 2026 | 3.619B |
| October 09, 2026 | 3.715B |
| October 08, 2026 | 3.444B |
| October 07, 2026 | 3.381B |
| October 06, 2026 | 3.427B |
| October 05, 2026 | 3.481B |
| October 02, 2026 | 3.296B |
| October 01, 2026 | 3.433B |
| September 30, 2026 | 3.439B |
| September 29, 2026 | 3.508B |
| September 28, 2026 | 3.609B |
| September 25, 2026 | 3.561B |
| September 24, 2026 | 3.575B |
| September 23, 2026 | 3.585B |
| September 22, 2026 | 3.636B |
| September 21, 2026 | 3.680B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.719B |
| September 17, 2026 | 3.488B |
| September 16, 2026 | 3.418B |
| September 15, 2026 | 3.813B |
| September 14, 2026 | 3.743B |
| September 11, 2026 | 3.665B |
| September 10, 2026 | 3.759B |
| September 09, 2026 | 3.655B |
| September 08, 2026 | 3.359B |
| September 04, 2026 | 3.675B |
| September 03, 2026 | 3.779B |
| September 02, 2026 | 3.635B |
| September 01, 2026 | 3.593B |
| August 31, 2026 | 3.469B |
| August 28, 2026 | 3.273B |
| August 27, 2026 | 3.343B |
| August 26, 2026 | 3.311B |
| August 25, 2026 | 3.374B |
| August 24, 2026 | 3.384B |
| August 21, 2026 | 3.475B |
| August 20, 2026 | 3.293B |
| August 19, 2026 | 3.234B |
| August 18, 2026 | 3.162B |
| August 17, 2026 | 3.218B |
| August 14, 2026 | 3.059B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 162.02M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 557.06M |
| ResMed, Inc. | 35.83B |
| Rockwell Medical, Inc. | 16.70M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.66M |
| Revenue (Quarterly) | 0.434M |
| Total Expenses (Quarterly) | 25.09M |
| EPS Diluted (Quarterly) | -0.3563 |
| Gross Profit Margin (Quarterly) | 37.10% |
| Profit Margin (Quarterly) | -5.68K% |
| Earnings Yield | -2.22% |
| Normalized Earnings Yield | -2.215 |